Cargando…
P056 Improvements in Daytime Function Items of the Insomnia Severity Index Are Correlated with a Positive Impact of Treatment on the Patient Global Impression Insomnia Scale
INTRODUCTION: Items 4-7 (daytime function [DF]) of the 7-item Insomnia Severity Index (ISI) can assess daytime impairment. In Study E2006-G000-303 (Study 303; NCT02952820), lemborexant (LEM), a dual-orexin receptor antagonist, was associated at 6 months (6mo) with both significant improvement in ISI...
Autores principales: | Drake, C, Gardiner, F, Yardley, J, Pinner, K, Moline, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591615/ http://dx.doi.org/10.1093/sleepadvances/zpad035.141 |
Ejemplares similares
-
P096 Subjective ratings of medication strength of lemborexant over 6 months in subjects with moderate or severe insomnia
por: Drake, C, et al.
Publicado: (2021) -
P097 Incidence of abnormal dreams and nightmares with lemborexant in adults with insomnia: results from two Phase 3 studies
por: Roth, T, et al.
Publicado: (2021) -
PSUN201 Efficacy and Safety of Lemborexant in Diabetic Patients With Insomnia Disorder
por: Moline, Margaret, et al.
Publicado: (2022) -
P057 Exploring the ‘Pharmacist Role’ in Insomnia Management and Care Provision: A Scoping Review
por: Basheti, M, et al.
Publicado: (2023) -
P073 Examining the Complex Relationships Among Insomnia, PTSD, Psychological Distress, and Suicidal Ideation in Firefighters.
por: Ferguson, S, et al.
Publicado: (2023)